49 related articles for article (PubMed ID: 17927506)
21. Conjugated linoleic acid suppresses colon carcinogenesis in azoxymethane-pretreated rats with long-term feeding of diet containing beef tallow.
Shiraishi R; Iwakiri R; Fujise T; Kuroki T; Kakimoto T; Takashima T; Sakata Y; Tsunada S; Nakashima Y; Yanagita T; Fujimoto K
J Gastroenterol; 2010 Jun; 45(6):625-35. PubMed ID: 20143104
[TBL] [Abstract][Full Text] [Related]
22. Isomer specificity of conjugated linoleic acid (CLA): 9E,11E-CLA.
Lee Y
Nutr Res Pract; 2008; 2(4):326-30. PubMed ID: 20016738
[TBL] [Abstract][Full Text] [Related]
23. Gastrointestinal microflora, food components and colon cancer prevention.
Davis CD; Milner JA
J Nutr Biochem; 2009 Oct; 20(10):743-52. PubMed ID: 19716282
[TBL] [Abstract][Full Text] [Related]
24. PPARgamma: The Portrait of a Target Ally to Cancer Chemopreventive Agents.
Sainis I; Vareli K; Karavasilis V; Briasoulis E
PPAR Res; 2008; 2008():436489. PubMed ID: 18779870
[TBL] [Abstract][Full Text] [Related]
25. PPAR Ligands for Cancer Chemoprevention.
Yasui Y; Kim M; Tanaka T
PPAR Res; 2008; 2008():548919. PubMed ID: 18483618
[TBL] [Abstract][Full Text] [Related]
26. Catalpa seed oil rich in 9t,11t,13c-conjugated linolenic acid suppresses the development of colonic aberrant crypt foci induced by azoxymethane in rats.
Suzuki R; Yasui Y; Kohno H; Miyamoto S; Hosokawa M; Miyashita K; Tanaka T
Oncol Rep; 2006 Nov; 16(5):989-96. PubMed ID: 17016582
[TBL] [Abstract][Full Text] [Related]
27. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057
[TBL] [Abstract][Full Text] [Related]
28. Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats.
Kawamori T; Tanaka T; Hara A; Yamahara J; Mori H
Cancer Res; 1995 Mar; 55(6):1277-82. PubMed ID: 7882322
[TBL] [Abstract][Full Text] [Related]
29. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon.
Rao CV; Desai D; Simi B; Kulkarni N; Amin S; Reddy BS
Cancer Res; 1993 Sep; 53(18):4182-8. PubMed ID: 8364913
[TBL] [Abstract][Full Text] [Related]
31. 9trans,11trans conjugated linoleic acid inhibits the development of azoxymethane-induced colonic aberrant crypt foci in rats.
Yasui Y; Suzuki R; Kohno H; Miyamoto S; Beppu F; Hosokawa M; Miyashita K; Tanaka T
Nutr Cancer; 2007; 59(1):82-91. PubMed ID: 17927506
[TBL] [Abstract][Full Text] [Related]
32. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs.
Pereira MA
Adv Exp Med Biol; 1999; 470():55-63. PubMed ID: 10709674
[TBL] [Abstract][Full Text] [Related]
33. Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency.
Corpet DE; Taché S
Nutr Cancer; 2002; 43(1):1-21. PubMed ID: 12467130
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
